This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Unspecified pneumoconiosis
J10_NASPNEUMOC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
43 |
4. Check minimum number of eventsNone |
43 |
5. Include endpointsNone |
43 |
6. Filter based on genotype QC (FinnGen only) |
43 |
Control definitions (FinnGen only)
- Control exclude
- J10_EXTERLUNG
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J60-J70
- Name in latin
- Pneumoconiosis non specificata
Similar endpoints
↥List of similar endpoints to
Unspecified pneumoconiosis
based on the number of shared cases.
Similar with more cases:
- Lung diseases due to external agents
- Diagnoses used for exclusion with ILD
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 463 | 139 | 313 |
| Only index persons | 245 | 81 | 164 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.00 | 0.01 |
| Only index persons | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 61.85 | 64.65 | 60.61 |
| Only index persons | 53.11 | 53.48 | 52.93 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 43 | 8 | 35 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.02 |
| Median age at first event (years) | 53.14 | 48.37 | 54.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044889) 12 lead EKG panel
12
215
0.39
2.04
5.3
4.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
58
1.94
0.88
3.7
4.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
25
0.00
0.82
0.0
2.8
—
4.1
—
0
25
(40761511) CBC panel - Blood by Automated count
26
308
0.61
0.76
17.8
14.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
25
2.13
0.75
1.6
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
25
2.13
0.75
2.4
4.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
8
123
0.57
0.68
8.1
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
26
303
0.64
0.63
19.3
15.0
mg/l
16.4
26.3
1.13
21
251
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
20
0.00
0.62
0.0
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
19
0.00
0.62
0.0
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
19
0.00
0.62
0.0
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
54
1.59
0.61
1.5
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
22
0.00
0.61
0.0
2.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
0
23
0.00
0.60
0.0
6.6
—
24.5
—
0
23
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
40
1.58
0.54
1.0
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
12
160
0.65
0.53
3.3
2.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
15
190
0.68
0.51
3.6
5.5
mmol/l
6.4
7.1
1.05
15
182
(40758558) Short blood count panel - Blood
10
71
1.53
0.44
4.5
7.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
17
136
1.41
0.43
4.9
5.9
%
55.3
58.3
0.62
17
126
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
15
0.00
0.42
0.0
3.8
—
38.8
—
0
8
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
16
0.00
0.42
0.0
5.5
—
118.4
—
0
16
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
16
0.00
0.42
0.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
16
0.00
0.42
0.0
14.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
6
42
1.50
0.37
2.0
2.6
%
2.1
1.8
—
6
36
(3023368) Bacteria identified in Blood by Culture
13
102
1.39
0.35
3.2
3.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
28
308
0.74
0.33
20.4
18.7
umol/l
83.5
89.5
0.40
28
308
(3011397) Hemoglobin [Presence] in Urine by Test strip
9
73
1.29
0.28
3.1
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
6
83
0.68
0.27
2.0
2.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
10
122
0.77
0.23
3.1
2.6
ug/l
85.6
150.8
—
10
110
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
42
1.21
0.22
1.0
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
42
1.21
0.22
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
11
0.00
0.21
0.0
5.6
—
1.1
—
0
11
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
11
0.00
0.21
0.0
6.0
—
0.8
—
0
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4094501)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
13
0.00
0.21
0.0
2.5
—
0.7
—
0
13
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
53.1
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
14
0.00
0.20
0.0
3.6
—
40.4
—
0
14
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
7.4
—
25.1
—
0
14
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
14
0.00
0.20
0.0
2.6
—
1.2
—
0
14
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11
91
1.28
0.20
2.0
3.4
u/l
29.9
30.4
0.04
11
82
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
59
1.22
0.19
1.9
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
140
0.80
0.19
2.9
4.4
%
20.9
21.6
—
7
69
(3004789) Transferrin [Mass/volume] in Serum or Plasma
7
61
1.18
0.19
2.6
2.6
g/l
2.3
2.3
—
7
56
(3024561) Albumin [Mass/volume] in Serum or Plasma
11
129
0.80
0.18
5.5
5.2
g/l
33.1
35.0
0.39
11
123
(3015736) pH of Urine
13
112
1.23
0.17
2.8
3.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
8
97
0.79
0.15
2.4
3.6
mmol/l
2.3
2.3
—
8
85
(3031040) Bacteria [#/volume] in Urine by Automated count
18
198
0.84
0.15
4.6
4.0
—
183.3
—
0
7
(3022948) Iron [Moles/volume] in Serum or Plasma
7
65
1.09
0.08
2.7
2.6
umol/l
10.1
14.2
—
7
57
(42870588) Differential panel, method unspecified - Blood
11
99
1.15
0.07
4.9
5.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
20
212
0.89
0.07
5.4
4.2
mm/h
16.3
14.1
0.15
20
196
(1761868) Lipid panel - Serum or Plasma
9
99
0.89
0.07
2.1
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
10
91
1.13
0.05
3.2
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
25
258
0.93
0.03
14.4
17.4
%
40.7
39.7
0.30
19
190
(3037467) Urinalysis macro (dipstick) panel - Urine
19
198
0.93
0.03
5.6
4.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
12
114
1.07
0.01
2.9
4.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
11
107
1.04
0.00
2.5
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
14
144
0.96
0.00
7.7
8.2
inr
1.3
1.3
—
5
46
(3018095) Leukocytes [#/volume] in Urine
12
118
1.02
0.00
3.8
3.7
e6/l
5.5
120.5
—
7
88
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790047)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.0
—
166.8
—
0
6
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
9
96
0.92
0.00
3.3
2.3
u/l
60.3
52.1
—
9
87
(3021960) Folate [Moles/volume] in Serum or Plasma
8
83
0.96
0.00
2.3
1.7
nmol/l
14.2
21.5
—
8
67
(44790049)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8
79
1.02
0.00
2.8
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
6
65
0.91
0.00
1.3
1.7
pmol/l
418.3
422.3
—
6
53
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
12
120
1.00
0.00
3.0
3.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
2.0
—
93.3
—
0
6
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
86.0
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
55
0.90
0.00
1.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
7
77
0.89
0.00
3.3
1.9
mg/l
2.3
3.3
—
7
70
(3044640) Blood type and Crossmatch panel - Blood
8
83
0.96
0.00
2.6
2.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
5.0
—
0
6
(3027008) Opiates [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.2
—
4.0
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.7
—
0
7
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
30.5
—
0
8
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
15.2
—
0
6
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
5
0.00
0.00
0.0
1.2
—
0.7
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
3.6
—
203.9
—
0
7
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
11.7
—
1.5
—
0
6
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
3.9
—
1.6
—
0
7
(3036489) Thrombin time
0
6
0.00
0.00
0.0
2.2
—
19.2
—
0
6
(3028271) Lactate [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
1.4
—
0
5
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
91.6
—
0
6
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
13.2
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.2
—
107.4
—
0
5
(3013512) EKG study
8
82
0.97
0.00
2.5
4.7
—
—
—
0
0
(44790048)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
3.9
—
7.2
—
0
7
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_NASPNEUMOC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have J10_NASPNEUMOC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: J10_NASPNEUMOC – Unspecified pneumoconiosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data